| Drug therapies for Parkinson's disease: a database analysis of patient compliance and persistence ML Tarrants, MF Denarié, J Castelli-Haley, J Millard, D Zhang The American journal of geriatric pharmacotherapy 8 (4), 374-383, 2010 | 78 | 2010 |
| Quantification of missing prescriptions in commercial claims databases: results of a cohort study MS Cepeda, D Fife, M Denarié, D Bradford, S Roy, Y Yuan pharmacoepidemiology and drug safety 26 (4), 386-392, 2017 | 43 | 2017 |
| System and Method for Determining Drug Usage by Indication M Denarie, M Leonhauser US Patent App. 14/501,422, 2016 | 2 | 2016 |
| The Effect of Medicare Part D on Parkinson's Disease Patients M Tarrants, T Shea, M Denarie, J Castelli-Haley Journal of the American Medical Directors Association 11 (3), B24, 2010 | 1 | 2010 |
| Representativeness in clinical trial planning: An epidemiologic examination of race and ethnicity leveraging multiple real-world data (RWD) sources in the United States EW Bratton, M Denarie, R Stolper, M Goins, E Gemmen PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 318-318, 2022 | | 2022 |
| Utilizing US prescription and claims data to better understand treatment dynamics of HIV/HCV co-infection patients in the second generation DAA era M Denarie, S Gubernick, N Panchatcharam, S Gao, S O'Neil, J Arluck JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 19, 2016 | | 2016 |
| Utilizing claims data to understand the relationships between diagnosing, prescribing, and dispensing patterns for HCV patients in the pre and post sofosbivir eras MF Denarie HEPATOLOGY 62, 743A-743A, 2015 | | 2015 |
| The Effect of Medicare Part D on Parkinson's Disease Patients: An Update (P04. 152) EB Grubb, M Denarie, W Stuchlak, D McDonald, J Castelli-Haley Neurology 80 (7_supplement), P04. 152-P04. 152, 2013 | | 2013 |
| Utilization Patterns of Strattera in Germany, Netherlands, Sweden and UK K Appenteng, A Camporeale, M Denarie, J Millard, S Motsko PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 21, 427-427, 2012 | | 2012 |
| The Effect of Medicare Part D on Parkinson's Disease Patients EB Grubb, T Shea, MF Denarie, ML Tarrants NEUROLOGY 76 (9), A560-A560, 2011 | | 2011 |
| CM3 THE IMPACT OF MEDICARE PART D ON ELDERLY PATIENTS'COMPLIANCE WITH STATINS D Zhang, SC Henderson, MF Denarie Value in Health 3 (12), A10, 2009 | | 2009 |
| PCV81 MEASURING THE IMPACT OF SOCIO-DEMOGRAPHIC CHARACTERISTICS ON PATIENT PERSISTENCE IN CHRONIC MARKETS SC Henderson, MF Denarie, Y Yuan Value in Health 3 (12), A156, 2009 | | 2009 |
| P2. 167 Parkinson's disease drug therapies: medication compliance and persistence M Tarrants, M Denarie, T Karabas, J Castelli-Haley, J Millard, D Zhang Parkinsonism and Related Disorders, S135, 2009 | | 2009 |
| PND29 PARKINSON'S DISEASE DRUG THERAPIES: MEDICATION COMPLIANCE AND PERSISTENCE ML Tarrants, MF Denarie, T Karabas, J Castelli-Haley, J Millard, D Zhang Value in Health 7 (12), A371, 2009 | | 2009 |
| Treatment pattern changes observed with the medicare part D coverage gap in patients utilizing insulin GH Skrepnek, M Denarie, C Conner, FM Forma DIABETES 57, A349-A349, 2008 | | 2008 |
| PDB68 AN ASSESSMENT OF THE IMPACT OF THE COVERAGE GAP UPON MEDICARE PART D BENEFICIARIES UTILIZING INSULIN GH Skrepnek, MF Denarie, C Conner, FM Forma Value in Health 3 (11), A237, 2008 | | 2008 |
